Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 96 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Vassiliki Kotoula  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Pectasides, D., Karavasilis V., Papaxoinis G., Gourgioti G., Makatsoris T., Raptou G., et al. (2015).  Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or. BMC Cancer. 15, 384.
Sanidas, I., Kotoula V., Ritou E., Daans J., Lenz C., Mairhofer M., et al. (2010).  The ratio of SRPK1/SRPK1a regulates erythroid differentiation in K562 leukaemic cells.. Biochim Biophys Acta. 1803(12), 1319-31.
Kotoula, V., Tsakiri K., Koliou G-A., Lazaridis G., Papadopoulou K., Giannoulatou E., et al. (2019).  Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome.. Clin Breast Cancer. 19(2), 113-125.e4.
S
Kim, S., Kotoula V., Hytiroglou P., Zardavas D., & Zhang L. (2009).  Significance of increased expression of decoy receptor 3 in chronic liver disease.. Dig Liver Dis. 41(8), 591-8.
Papaxoinis, G., Kotoula V., Alexopoulou Z., Kalogeras K. T., Zagouri F., Timotheadou E., et al. (2015).  Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.. PLoS One. 10(10), e0140293.
Pazaitou-Panayiotou, K., Janson E. Tiensuu, Koletsa T., Kotoula V., Stridsberg M., Karkavelas G., et al. (2012).  Somatostatin receptor expression in non-medullary thyroid carcinomas.. Hormones (Athens). 11(3), 290-6.
Kotoula, V., Lambaki S., Televantou D., Kalogera-Fountzila A., Nikolaou A., Markou K., et al. (2011).  STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN.. Transl Oncol. 4(1), 47-58.
Papakonstantinou, E., Klagas I., Karakiulakis G., Hostettler K., S'ng C. Teck, Kotoula V., et al. (2012).  Steroids and β2-agonists regulate hyaluronan metabolism in asthmatic airway smooth muscle cells.. Am J Respir Cell Mol Biol. 47(6), 759-67.
Pentheroudakis, G., Kotoula V., Fountzilas E., Kouvatseas G., Basdanis G., Xanthakis I., et al. (2014).  A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).. BMC Cancer. 14, 111.
Koletsa, T., Kotoula V., Hytiroglou P., Spanos P., & Papadimitriou C. S. (2004).  Synovial sarcoma of the heart.. Virchows Arch. 444(5), 477-9.
T
Kotoula, V., Charalambous E., Biesmans B., Malousi A., Vrettou E., Fountzilas G., et al. (2009).  Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.. PLoS One. 4(11), e7746.
Razis, E., Kotoula V., Koliou G-A., Papadopoulou K., Vrettou E., Giannoulatou E., et al. (2020).  Is There an Independent Role of TERT and NF1 in High Grade Gliomas?. Transl Oncol. 13(2), 346-354.
Fountzilas, G., Giannoulatou E., Alexopoulou Z., Zagouri F., Timotheadou E., Papadopoulou K., et al. (2016).  TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.. Oncotarget. 7(22), 32731-53.
Hatzibougias, D. I., Fouzas I., Bobos M., Papanikolaou V., Daoudaki M., Kotoula V., et al. (2016).  Tubular Pyloric Gland Adenoma of the Left and Right Hepatic Ducts: Report of a Unique Case With Immunohistochemical and Molecular Studies.. Int J Surg Pathol. 24(4), 347-52.
Kotoula, V., Lakis S., Vlachos I. S., Giannoulatou E., Zagouri F., Alexopoulou Z., et al. (2016).  Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.. PLoS One. 11(9), e0163138.
Nikolaidi, A., Kotoula V., Koliou G-A., Giannoulatou E., Papadopoulou K., Zagouri F., et al. (2020).  Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast Cancer.. Cancer Genomics Proteomics. 17(2), 181-193.
Zardavas, D., Marvelde L. Te, Milne R. L., Fumagalli D., Fountzilas G., Kotoula V., et al. (2018).  Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.. J Clin Oncol. 36(10), 981-990.
Kotoula, V., Chatzopoulos K., Lakis S., Alexopoulou Z., Timotheadou E., Zagouri F., et al. (2016).  Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials.. Oncotarget. 7(4), 5074-87.
U
Koletsa, T., Kotoula V., Christoforidou A., Pantelidou P., Petrakis G., Tsatalas C., et al. (2013).  An unusual case of biphenotypic, bigenotypic mature lymphoma.. J Clin Pathol. 66(12), 1090-2.
V
Koutras, A. K., Kotoula V., Papadimitriou C., Dionysopoulos D., Zagouri F., Kalofonos H. P., et al. (2014).  Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel.. Pharmacogenomics J. 14(3), 248-55.
Iliadis, G., Kotoula V., Chatzisotiriou A., Televantou D., Eleftheraki A. G., Lambaki S., et al. (2012).  Volumetric and MGMT parameters in glioblastoma patients: survival analysis.. BMC Cancer. 12, 3.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές